📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing (2024)

First Author: Aguti S

Attributed to: Establishing a National Platform for the Development of Nucleic Acid Therapy for Rare Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2024.102237

Publication URI: http://dx.doi.org/10.1016/j.omtn.2024.102237

Type: Journal Article/Review

Parent Publication: Molecular Therapy - Nucleic Acids

Issue: 3